Colon and rectum

Lack (deficiency) of vitamin A in developed countries is very rare. In particular, leads to visual disturbances - especially night vision. Vitamin A is absorbed in the intestine, like other fat-soluble vitamins.

In the past it was assumed that vitamin D could play a role in preventing colon cancer. This assumption was also confirmed in a recent study conducted at Harvard Medical Faculty American University in Boston. Doctors found that patients with higher levels of vitamin D in their blood, have a lower risk of death doubled for colorectal cancer compared with those who had low concentrations of this vitamin.

Analysis of earlier studies have shown that vitamin D at higher levels may reduce the risk of cancer of the colon and rectum. The mechanism and the optimal doses are not yet known. When studying the role of vitamin D to cancer of the colon and rectum were analyzed various studies associated with this problem.

According to a new study published in the journal Internal Journal of Cancer Vitamin B can significantly contribute to reducing the risk of cancer of the colon and rectum (the so-called colorectal cancer). These protective effects of a series of B vitamins namely folic acid. This is sometimes referred to ...

Several studies provided evidence that folic acid may also protect humans against cancer of the colon, breast and lung cancer. Folic acid, also known as vitamin B9, according to scientists, we can protect against various cancers. A study of 89,000 women in the United States brought the knowledge that a minimum 15-day annual revenue of more than 400 micrograms of this substance reduces the risk of colon cancer by 75 percent.

According to a study published in the journal Cancer Epidemiology, Biomarkers and Prevention can add calcium and vitamin D to promote healthy cells of the colon and rectum. It was found that the combination of minerals and vitamins can normalize the health of cells in the colon and rectum. Researchers from Emory University, University of Minnesota, National Cancer Institute and the National Institutes of Health conducted a pilot, randomized, double-blind, placebo-controlled clinical study, which was attended by 92 men and women with a history of benign tumors of the colon and rectum.